Loading clinical trials...
Loading clinical trials...
Prospective, Multi-Center Study of the ClariCore Optical Biopsy System in Patients Undergoing Transrectal Ultrasound (TRUS)-Guided Prostate Biopsy for Real-Time Tissue Evaluation
The purpose of this study is to demonstrate the effectiveness and safety of the ClariCore System in obtaining prostate biopsies with device feedback that provides real-time tissue classification.
The purpose of this study is to collect information on prostate biopsies using the ClariCore System. The ClariCore System is designed to improve how the biopsies are being collected from the prostate by using light sensors (fiber optics) that can see changes in the prostate tissue. Researchers will study the information collected from the light sensors to study a method that has been developed to tell the difference between normal and suspicious (possibly cancerous) prostate tissue during the biopsy. This information will be given to the doctor in real-time. From this study, researchers hope to learn if this method can tell the difference between normal and suspicious prostate tissue, and if this can improve the evaluation of prostate tissue (biopsies).
Age
22 - No limit years
Sex
MALE
Healthy Volunteers
No
The Urology Center of Colorado
Denver, Colorado, United States
Brady Urological Institute, Johns Hopkins Hospital
Baltimore, Maryland, United States
NYU Langone Urology Associates
New York, New York, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Urology of San Antonio
San Antonio, Texas, United States
Start Date
April 25, 2018
Primary Completion Date
January 1, 2020
Completion Date
December 1, 2020
Last Updated
February 15, 2019
325
ESTIMATED participants
ClariCore Optical Biopsy System
DEVICE
Lead Sponsor
Precision Biopsy, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions